US Stock MarketDetailed Quotes
ELAT Elanco Animal Health-TEU
- 21.320
- 0.0000.00%
Close Jan 31 16:00 ET
10.53BMarket Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open21.320Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)494.10MShares21.53052wk High1.56P/B10.53BFloat Cap19.13052wk Low--Dividend TTM494.10MShs Float49.458Historical High--Div YieldTTM0.00%Amplitude17.451Historical Low--Avg Price1Lot Size
Elanco Animal Health-TEU Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -9.11%1.03B | -7.97%1.18B | -1.37%1.23B | 45.59%4.77B | -2.28%1.11B | 27.08%1.13B | 118.26%1.28B | 88.75%1.24B | 6.58%3.27B | 44.73%1.14B |
| Operating revenue | -9.11%1.03B | -7.97%1.18B | -1.37%1.23B | 45.59%4.77B | -2.28%1.11B | 27.08%1.13B | 118.26%1.28B | 88.75%1.24B | 6.58%3.27B | 44.73%1.14B |
| Cost of revenue | -5.98%472M | -12.16%484M | -10.54%509M | 28.01%2.13B | -14.09%512M | 13.57%502M | 86.15%551M | 70.87%569M | 13.40%1.67B | 45.44%596M |
| Gross profit | -11.61%556M | -4.81%693M | 6.39%716M | 63.82%2.63B | 10.68%601M | 40.40%629M | 151.03%728M | 107.08%673M | 0.31%1.61B | 43.96%543M |
| Operating expense | -12.65%504M | -8.22%558M | -7.88%538M | 38.38%2.33B | -13.71%560M | 24.89%577M | 124.35%608M | 94.02%584M | 36.83%1.68B | 113.56%649M |
| Selling and administrative expenses | -12.87%298M | -10.91%343M | -8.05%320M | 40.96%1.4B | -11.80%329M | 23.02%342M | 136.20%385M | 91.21%348M | 31.05%996M | 100.86%373M |
| Research and development costs | -17.02%78M | -12.77%82M | -8.99%81M | 12.84%369M | -18.58%92M | 6.82%94M | 59.32%94M | 32.84%89M | 21.11%327M | 68.15%113M |
| Depreciation amortization depletion | -9.22%128M | 3.10%133M | -6.80%137M | 54.44%556M | -14.72%139M | 46.88%141M | 163.27%129M | 182.69%147M | 80.00%360M | 219.61%163M |
| -Depreciation and amortization | -9.22%128M | 3.10%133M | -6.80%137M | 54.44%556M | -14.72%139M | 46.88%141M | 163.27%129M | 182.69%147M | 80.00%360M | 219.61%163M |
| Operating profit | 0.00%52M | 12.50%135M | 100.00%178M | 492.21%302M | 138.68%41M | 471.43%52M | 531.58%120M | 270.83%89M | -120.75%-77M | -244.61%-106M |
| Net non-operating interest income expense | 0.00%-60M | -11.67%-67M | 14.75%-52M | -57.33%-236M | 9.84%-55M | -25.00%-60M | -140.00%-60M | -281.25%-61M | -89.87%-150M | -224.47%-61M |
| Non-operating interest expense | 0.00%60M | 11.67%67M | -14.75%52M | 57.33%236M | -9.84%55M | 25.00%60M | 140.00%60M | 281.25%61M | 89.87%150M | 224.47%61M |
| Other net income (expense) | 72.13%-34M | 70.95%-86M | 49.07%-55M | -42.25%-633M | 29.14%-107M | 17.01%-122M | -316.90%-296M | -42.11%-108M | -107.94%-445M | -155.93%-151M |
| Special income (charges) | 78.33%-26M | 71.99%-86M | 60.68%-46M | -5.46%-657M | 32.34%-113M | 54.20%-120M | -157.98%-307M | -56.00%-117M | -234.95%-623M | -220.54%-167M |
| -Less：Restructuring and merger&acquisition | -3.57%27M | -19.35%25M | -83.18%18M | -52.78%272M | -16.67%105M | -89.27%28M | -72.32%31M | 37.18%107M | 276.47%576M | 187.67%126M |
| -Less:Impairment of capital assets | -101.79%-1M | -78.23%59M | 154.55%28M | 855.56%344M | -79.31%6M | 5,500.00%56M | 6,675.00%271M | 1,000.00%11M | 9.09%36M | 249.40%29M |
| -Less:Other special charges | ---- | -60.00%2M | ---- | 173.33%41M | -83.33%2M | --36M | 66.67%5M | ---1M | --15M | --12M |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --4M | --0 |
| Other non- operating income (expenses) | -300.00%-8M | ---- | -200.00%-9M | -86.52%24M | -62.50%6M | -101.74%-2M | -77.08%11M | 1,000.00%9M | 735.71%178M | 331.88%16M |
| Income before tax | 67.69%-42M | 92.37%-18M | 188.75%71M | 15.63%-567M | 61.95%-121M | 37.80%-130M | -206.49%-236M | -17.65%-80M | -961.54%-672M | -6,966.67%-318M |
| Income tax | 126.92%7M | 115.38%4M | 221.05%23M | 15.18%-95M | -580.00%-24M | 64.86%-26M | -8.33%-26M | 0.00%-19M | -1,220.00%-112M | 2.04%5M |
| Net income | 52.88%-49M | 89.52%-22M | 178.69%48M | 15.71%-472M | 69.97%-97M | 22.96%-104M | -296.23%-210M | -24.49%-61M | -923.53%-560M | -3,336.17%-323M |
| Net income continuous Operations | 52.88%-49M | 89.52%-22M | 178.69%48M | 15.71%-472M | 69.97%-97M | 22.96%-104M | -296.23%-210M | -24.49%-61M | -923.53%-560M | -3,336.17%-323M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 52.88%-49M | 89.52%-22M | 178.69%48M | 15.71%-472M | 69.97%-97M | 22.96%-104M | -296.23%-210M | -24.49%-61M | -923.53%-560M | -3,336.17%-323M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 52.88%-49M | 89.52%-22M | 178.69%48M | 15.71%-472M | 69.97%-97M | 22.96%-104M | -296.23%-210M | -24.49%-61M | -923.53%-560M | -3,336.17%-323M |
| Basic earnings per share | ||||||||||
| Diluted earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg